# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to...
Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced the closing of its refinanced first lien cre...
JP Morgan analyst Lisa Gill upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Underweight to Neutral and raises the price...
UBS analyst A.J. Rice upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Sell to Neutral and raises the price target from ...
Barclays analyst Andrew Mok upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Equal-Weight to Overweight and raises the p...
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sell and raises the price target from $5 to $6...
Raymond James analyst John Ransom upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Market Perform to Outperform and anno...